Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex.

Overwater IE, Rietman AB, Mous SE, Bindels-de Heus K, Rizopoulos D, Ten Hoopen LW, van der Vaart T, Jansen FE, Elgersma Y, Moll HA, de Wit MY; ENCORE Expertise Centre for Neurodevelopmental Disorders.

Neurology. 2019 Jul 9;93(2):e200-e209. doi: 10.1212/WNL.0000000000007749. Epub 2019 Jun 19.

PMID:
31217257
2.

Response to Wollschläger, Blettner, and Pokora.

Meulepas JM, Ronckers CM, Smets AMJB, Nievelstein RAJ, Gradowska P, Lee C, Jahnen A, van Straten M, de Wit MY, Zonnenberg B, Klein WM, Merks JH, Visser O, van Leeuwen FE, Hauptmann M.

J Natl Cancer Inst. 2019 Apr 12. pii: djz062. doi: 10.1093/jnci/djz062. [Epub ahead of print] No abstract available.

PMID:
31131847
3.

Response.

Meulepas JM, Ronckers CM, Smets AMJB, Nievelstein RAJ, Gradowska P, Lee C, Jahnen A, van Straten M, de Wit MY, Zonnenberg B, Klein WM, Merks JH, Visser O, van Leeuwen FE, Hauptmann M.

J Natl Cancer Inst. 2019 Apr 12. pii: djz062. doi: 10.1093/jnci/djz062. [Epub ahead of print] No abstract available.

PMID:
30977817
4.

Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands.

Meulepas JM, Ronckers CM, Smets AMJB, Nievelstein RAJ, Gradowska P, Lee C, Jahnen A, van Straten M, de Wit MY, Zonnenberg B, Klein WM, Merks JH, Visser O, van Leeuwen FE, Hauptmann M.

J Natl Cancer Inst. 2019 Mar 1;111(3):256-263. doi: 10.1093/jnci/djy104.

5.

Antibody responses to GalC in severe and complicated childhood Guillain-Barré syndrome.

Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, de Wit MY, Unger WWJ, Berger C, van Rossum AMC, Jacobs BC.

J Peripher Nerv Syst. 2018 Mar;23(1):67-69. doi: 10.1111/jns.12243. No abstract available.

6.

Cortical dysplasia and autistic trait severity in children with Tuberous Sclerosis Complex: a clinical epidemiological study.

Mous SE, Overwater IE, Vidal Gato R, Duvekot J, Ten Hoopen LW, Lequin MH, de Wit MY, Dieleman GC.

Eur Child Adolesc Psychiatry. 2018 Jun;27(6):753-765. doi: 10.1007/s00787-017-1066-z. Epub 2017 Oct 23.

7.

Incidental Findings on Brain Imaging in the General Pediatric Population.

Jansen PR, Dremmen M, van den Berg A, Dekkers IA, Blanken LME, Muetzel RL, Bolhuis K, Mulder RM, Kocevska D, Jansen TA, de Wit MY, Neuteboom RF, Polderman TJC, Posthuma D, Jaddoe VWV, Verhulst FC, Tiemeier H, van der Lugt A, White TJH.

N Engl J Med. 2017 Oct 19;377(16):1593-1595. doi: 10.1056/NEJMc1710724. No abstract available.

PMID:
29045203
8.

Motor nerve excitability after childhood Guillain-Barré syndrome.

Drenthen J, Roodbol J, Maathuis EM, Catsman-Berrevoets CE, Blok JH, de Wit MY, Jacobs BC.

J Peripher Nerv Syst. 2017 Jun;22(2):100-105. doi: 10.1111/jns.12213.

PMID:
28432749
9.

Author response: Sirolimus for epilepsy in children with tuberous sclerosis complex: A randomized controlled trial.

de Wit MY, Overwater IE.

Neurology. 2017 Mar 7;88(10):1008. doi: 10.1212/WNL.0000000000003704. No abstract available.

PMID:
28265043
10.

Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria.

Roodbol J, de Wit MY, van den Berg B, Kahlmann V, Drenthen J, Catsman-Berrevoets CE, Jacobs BC.

J Neurol. 2017 May;264(5):856-861. doi: 10.1007/s00415-017-8429-8. Epub 2017 Mar 1.

11.

Genotype and brain pathology phenotype in children with tuberous sclerosis complex.

Overwater IE, Swenker R, van der Ende EL, Hanemaayer KB, Hoogeveen-Westerveld M, van Eeghen AM, Lequin MH, van den Ouweland AM, Moll HA, Nellist M, de Wit MY.

Eur J Hum Genet. 2016 Dec;24(12):1688-1695. doi: 10.1038/ejhg.2016.85. Epub 2016 Jul 13.

12.

Transmission and protection in leprosy: indications of the role of mucosal immunity.

Ramaprasad P, Fernando A, Madhale S, Rao JR, Edward VK, Samson PD, Klatser PR, de Wit MY, Smith WC, Cree IA.

Lepr Rev. 1997 Dec;68(4):301-15.

PMID:
9503866
13.

Polymerase chain reaction of nasal swabs from tuberculosis patients and their contacts.

Warndorff DK, Glynn JR, Fine PE, Jamil S, de Wit MY, Munthali MM, Stoker NG, Klatser PR.

Int J Lepr Other Mycobact Dis. 1996 Dec;64(4):404-8.

PMID:
9030106
14.

The epidemiology of Mycobacterium leprae: recent insight.

van Beers SM, de Wit MY, Klatser PR.

FEMS Microbiol Lett. 1996 Mar 1;136(3):221-30. Review.

PMID:
8867377
15.

A 46 kDa integral membrane protein from Mycobacterium leprae resembles a number of bacterial and mammalian membrane transport proteins.

Oskam L, Hartskeerl RA, Hermans CJ, de Wit MY, Jarings GH, Nicholls RD, Klatser PR.

Microbiology. 1995 Aug;141 ( Pt 8):1963-8.

PMID:
7551058
16.

Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia.

Hatta M, van Beers SM, Madjid B, Djumadi A, de Wit MY, Klatser PR.

Trans R Soc Trop Med Hyg. 1995 Jul-Aug;89(4):381-5.

PMID:
7570870
18.

Detection of Mycobacterium leprae nasal carriers in populations for which leprosy is endemic.

Klatser PR, van Beers S, Madjid B, Day R, de Wit MY.

J Clin Microbiol. 1993 Nov;31(11):2947-51.

19.

Polymerase chain reaction for detection of Mycobacterium leprae in nasal swab specimens.

de Wit MY, Douglas JT, McFadden J, Klatser PR.

J Clin Microbiol. 1993 Mar;31(3):502-6.

20.

A simple colorimetric assay for detection of amplified Mycobacterium leprae DNA.

van der Vliet GM, de Wit MY, Klatser PR.

Mol Cell Probes. 1993 Feb;7(1):61-6.

PMID:
8455642
21.

Application of a polymerase chain reaction for the detection of Mycobacterium leprae in skin tissues.

de Wit MY, Faber WR, Krieg SR, Douglas JT, Lucas SB, Montreewasuwat N, Pattyn SR, Hussain R, Ponnighaus JM, Hartskeerl RA, et al.

J Clin Microbiol. 1991 May;29(5):906-10.

22.
24.

A major immunogenic 36,000-molecular-weight antigen from Mycobacterium leprae contains an immunoreactive region of proline-rich repeats.

Thole JE, Stabel LF, Suykerbuyk ME, De Wit MY, Klatser PR, Kolk AH, Hartskeerl RA.

Infect Immun. 1990 Jan;58(1):80-7.

25.

Polymerase chain reaction for the detection of Mycobacterium leprae.

Hartskeerl RA, de Wit MY, Klatser PR.

J Gen Microbiol. 1989 Sep;135(9):2357-64.

PMID:
2697743
26.

Evaluation of Mycobacterium leprae antigens in the monitoring of a dapsone-based chemotherapy of previously untreated lepromatous patients in Cebu, Philippines.

Klatser PR, de Wit MY, Fajardo TT, Cellona RV, Abalos RM, de la Cruz EC, Madarang MG, Hirsch DS, Douglas JT.

Lepr Rev. 1989 Sep;60(3):178-86.

PMID:
2682104
27.

Evaluation of Mycobacterium leprae antigens in the serological monitoring of a clofazimine-based chemotherapeutic study of dapsone resistant lepromatous leprosy patients in Cebu, Philippines.

Douglas JT, Hirsch DS, Fajardo TT, Cellona RV, Abalos RM, de la Cruz EC, Madarang MG, de Wit MY, Klatser PR.

Lepr Rev. 1989 Mar;60(1):8-19.

PMID:
2657302
28.

Purification and characterization of a 36 kDa antigen of Mycobacterium leprae.

de Wit MY, Klatser PR.

J Gen Microbiol. 1988 Jun;134(6):1541-8.

PMID:
3065448
29.

Characterization of the 36 K antigen of Mycobacterium leprae.

Klatser PR, Hartskeerl RA, van Schooten WC, Kolk AH, van Rens MM, de Wit MY.

Lepr Rev. 1986 Dec;57 Suppl 2:77-81. No abstract available.

PMID:
3553806
30.

Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells.

Ottenhoff TH, Klatser PR, Ivanyi J, Elferink DG, de Wit MY, de Vries RR.

Nature. 1986 Jan 2-8;319(6048):66-8.

PMID:
2417123
31.

An ELISA-inhibition test using monoclonal antibody for the serology of leprosy.

Klatser PR, De Wit MY, Kolk AH.

Clin Exp Immunol. 1985 Dec;62(3):468-73.

Supplemental Content

Loading ...
Support Center